Review
Sep 2026
Prekallikrein: the catalytic crossroads of inflammation and thrombosis
Current evidence positions prekallikrein as a promising therapeutic target that may allow selective inhibition of thromboinflammatory processes without impairing hemostasis.
Aditya K. Malhotra, Arjun Tomer, Ocean Punsalan et al.
· Current opinion in hematolog... · 0 citations